(Q44484392)

3 December 2017

title

Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta (English)

1 reference

3 December 2017

1 reference

1 reference

Masaki Fujita

1

1 reference

3 December 2017

John M Shannon

2

1 reference

3 December 2017

Osamu Morikawa

3

1 reference

3 December 2017

Jack Gauldie

4

1 reference

3 December 2017

Nobuyuki Hara

5

1 reference

3 December 2017

Robert J Mason

6

1 reference

3 December 2017

publication date

19 June 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

3 December 2017

published in

1 reference

3 December 2017

volume

29

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

669-676

1 reference

The tumor necrosis factor ligand and receptor families.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Effect of adenovector-mediated gene transfer of keratinocyte growth factor on the proliferation of alveolar type II cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Alveolitis and collapse in the pathogenesis of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Role of Interleukin-10 in the Lung Response to Silica in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0046OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2002-0046OC

1 reference

3 December 2017

1 reference